Editing Ai Natural Sciences (section)

== <span style="color: #FFFFFF;">Understanding</span> ==
Science generates data at scales and speeds that no human team can analyze manually. The Large Hadron Collider produces ~1 petabyte of data per second. Genomics databases contain sequences for hundreds of thousands of organisms. The Vera Rubin Observatory will image the entire sky every few nights. AI is the only tool capable of extracting knowledge from these data streams.

'''The AlphaFold revolution''': Before AlphaFold 2 (2020), predicting how a protein folds from its amino acid sequence was an unsolved 50-year-old grand challenge. The problem matters because protein function is determined by structure — understanding structure is the key to understanding disease and designing drugs. AlphaFold 2 achieved near-experimental accuracy (under 1 Å RMSD) on most proteins, and DeepMind released predictions for essentially all known proteins (~200 million structures). This has transformed structural biology.

'''How does AlphaFold work?''' At its core, AlphaFold uses:
1. Multiple Sequence Alignments (MSAs): evolutionary information about which amino acids co-vary across species — implying spatial proximity
2. Evoformer: a specialized transformer that processes both MSA and pairwise distance information
3. Structure module: predicts 3D coordinates by reasoning about relative orientations of residue frames

'''Physics-Informed Neural Networks (PINNs)''' encode physical laws directly into the loss function. Instead of just minimizing prediction error on data, the model is also penalized for violating differential equations governing the system. A PINN modeling heat diffusion must satisfy ∂T/∂t = α∇²T at every point — even without training data there. This data-efficient approach is powerful for physics problems where data is scarce but equations are known.

'''The generative chemistry frontier''': Given a target protein structure, can AI design a drug molecule that fits into its binding site? Diffusion models (DiffSBDD, DiffDock), graph neural networks (MPNN), and transformer-based approaches now generate drug-like molecules with optimized binding affinity, ADMET properties, and synthetic accessibility — accelerating a process that previously took years.
</div>

<div style="background-color: #8B0000; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">